Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

  • This share is currently suspended. It was suspended at a price of 164.40
  • There is currently no data for APAX

Director/PDMR Shareholding

17 Sep 2015 15:10

RNS Number : 4201Z
Apax Global Alpha Limited
17 September 2015
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED STATES OR TO "US PERSONS" (AS DEFINED IN REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT")) OR INTO OR WITHIN AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN. RECIPIENTS OF THIS ANNOUNCEMENT IN JURISDICTIONS OUTSIDE THE UK SHOULD INFORM THEMSELVES ABOUT AND OBSERVE ANY APPLICABLE LEGAL REQUIREMENTS IN THEIR JURISDICTIONS. IN PARTICULAR, THE DISTRIBUTION OF THE ANNOUNCEMENT MAY BE RESTRICTED BY LAW IN CERTAIN JURISDICTIONS.

 

Note that any references in this announcement to Apax Global Alpha Limited have been abbreviated to "AGA" or "the Company". Any references to Apax Partners LLP have been abbreviated to "Apax Partners" or "the Investment Adviser"

 

17 September 2015

FOR IMMEDIATE RELEASE

 

Apax Global Alpha Limited

Notice of Transactions of Persons Discharging Managerial Responsibilities ("PDMRs")

 

This notification is made in accordance with DTR 3.1.4R(1)(a) of the Disclosure and Transparency Rules.

 

Transfer of Shares

 

The Company has been informed on 17 September 2015, that John Megrue, an employee of Apax Partners and a person discharging managerial responsibilities, has transferred 4,578,805 ordinary shares of no par value in the Company (the "Ordinary Shares") to Lizanne Megrue (the "Transfer").

 

No consideration was paid for the Transfer. The Ordinary Shares transferred remain subject to the same lock-up arrangements agreed in connection with the Company's IPO on 15 June 2015, details of which are summarised in the Company's prospectus dated 21 May 2015, available on the Company's website.

 

The Transfer is unconnected to the Company and forms part of a domestic transfer between John Megrue and Lizanne Megrue. The beneficial interest to the Ordinary Shares transferred is held by Lizanne Megrue.

 

Investor Relations

Lorraine Rees

 

Telephone:

+44 (0)20 7872 6300

Email:

investor.relations@apaxglobalalpha.com

 

Media enquiries (Apax Global Alpha Limited)

Alex Jones

 

Telephone:

+44 (0)20 7952 2000

Email:

aga@greenbrookpr.com

 

Media enquiries (Apax Partners LLP)

Alex Wessendorff

 

Telephone:

+44 (0)20 7872 6461

Email:

alex.wessendorff@apax.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBSGDCCGBBGUR
Date   Source Headline
14th Mar 20197:00 amRNSNotice of AGM
13th Mar 20196:05 pmRNSDirector/PDMR Shareholding
5th Mar 20197:00 amRNSUpdated Key Information Document
5th Mar 20197:00 amRNS2018 Annual Dividend
5th Mar 20197:00 amRNS2018 Annual Report and Accounts
5th Mar 20197:00 amRNS2018 Final Results
26th Feb 201911:42 amRNSExits from Exact Software and AssuredPartners
29th Jan 20197:00 amRNSApax Funds' Valuations as at 31 December 2018
21st Dec 20181:48 pmRNSDirector/PDMR Shareholding
21st Dec 201812:09 pmRNSInclusion in FTSE 250 Index
19th Dec 20186:30 pmRNSShire
27th Nov 201810:00 amRNSPDMR Dealing - Share Transfers
23rd Nov 20183:07 pmRNSDirector Dealings - Chris Ambler
14th Nov 20187:00 amRNSNotice of Annual Results
7th Nov 20187:00 amRNSNew revolving credit facility
7th Nov 20187:00 amRNSQuarterly results for the period ended 30 Sep 2018
13th Sep 20184:29 pmRNSDirector Dealings - Chris Ambler
5th Sep 20185:12 pmRNSNotice of Quarterly Results 30 Sept 2018
14th Aug 20187:00 amRNS2018 Interim Dividend
14th Aug 20187:00 amRNS2018 Interim Report and Accounts
14th Aug 20187:00 amRNS2018 Interim Results Highlights
31st Jul 20187:00 amRNSApax Funds' Valuations as at 30 June 2018
18th Jul 20183:00 pmRNSHolding(s) in Company
3rd Jul 201810:00 amRNSDirectorate Change
2nd Jul 20183:00 pmRNSDirector Declaration
14th Jun 20187:00 amRNSNotice of Interim Results 2018
6th Jun 20187:00 amRNSAGA Investor Day
23rd May 201810:00 amRNSEU GDPR Data Privacy Notices
3rd May 20187:00 amRNSQuarterly results for 31 March 2018
1st May 20183:04 pmRNSResult of AGM
26th Apr 201812:47 pmRNSDirectorate Change
16th Apr 20187:25 amRNSNotice of Investor Day
19th Mar 20184:46 pmRNSDirector Declaration
19th Mar 201812:00 pmRNSNotice of AGM
14th Mar 20182:45 pmRNSNotice of Quarterly Results Q1 2018
6th Mar 20187:00 amRNS2017 Annual Dividend Announcement
6th Mar 20187:00 amRNS2017 Annual Report and Accounts
6th Mar 20187:00 amRNS2017 Final Results
6th Mar 20187:00 amRNSUpdated Key Information Document
31st Jan 20185:25 pmRNSDirector/PDMR Shareholding
30th Jan 20187:00 amRNSApax Funds' Valuations as at 31 December 2017
4th Jan 20185:09 pmRNSDirectorate Change - Sarah Evans
2nd Jan 201812:00 pmRNSPublication of Key Information Document
15th Dec 20172:06 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSNotice of Annual Results
1st Nov 20177:00 amRNSQ3 2017 Results Highlights
11th Sep 20177:00 amRNS3Q17 Financial Highlights
31st Aug 20172:57 pmRNSAGA's FTSE Index Inclusion
17th Aug 20177:00 amRNS2017 Interim Dividend
17th Aug 20177:00 amRNS2017 Interim Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.